Stability data gaps during WHO PQ assessment – CAPA expectations for PQ approval



Published on 29/01/2026

Addressing Stability Data Gaps During WHO PQ Assessments for Improved CAPA Outcomes

The WHO Prequalification (PQ) process is a critical gateway for pharmaceutical companies looking to supply medicines to low- and middle-income countries. However, lapses in stability data can lead to significant delays or outright failures in receiving the much-coveted PQ approval. This article serves as an actionable playbook for addressing stability data gaps, focusing on effective corrective and preventive actions (CAPA) and ensuring compliance with Good Manufacturing Practices (GMP).

By following this structured guide, professionals in manufacturing, quality control, quality assurance, engineering, and regulatory affairs will be equipped to quickly triage issues, analyze root causes, implement controls, and prepare inspection-ready documentation. The goal is to mitigate risks associated with stability data gaps and enhance the efficacy of the PQ process.

Symptoms/Signals on the Floor or in the Lab

Identifying early warning signs of stability data issues is crucial to preventing downstream problems during a WHO PQ assessment. Here are some common symptoms:

  • Missing Stability
Data: Incomplete datasets on shelf-life studies or lack of documentation for specific batch sizes.
  • Out-of-Specification (OOS) Results: Test results that deviate from specifications can indicate underlying stability issues.
  • Trends in Data: Anomalies or irregularities in stability data across batches, suggesting potential systemic problems.
  • Inconsistent Descriptions: Discrepancies between the stability protocol and actual laboratory findings or reports.
  • Feedback from Regulatory Bodies: Requests for additional information from the WHO or other regulatory agencies during the PQ process.
  • Likely Causes

    Understanding the possible causes for stability data gaps is essential in addressing the root of the problem. Below, we categorize these likely causes:

    Category Likely Causes
    Materials Substandard raw materials, improper storage conditions, or expired excipients.
    Method Inconsistent testing procedures, insufficient analytical methods, or lack of validation for test methods.
    Machine Improper calibration, malfunctioning equipment, or lack of maintenance.
    Man Inadequate training, lack of documentation practices, or human error during testing.
    Measurement Inconsistent measurement tools, absence of control charts, or misinterpretation of results.
    Environment Non-compliance with environmental monitoring (temperature/humidity) affecting stability.

    Immediate Containment Actions (first 60 minutes)

    Time is of the essence when dealing with stability data gaps. The first hour following identification of a potential issue is critical. Here are the steps to contain the problem:

    1. Stop Production: Immediately halt further operations that may contribute to or exacerbate the issue.
    2. Isolate Affected Batches: Segregate all batches of the affected product to prevent any distribution or use.
    3. Notify Key Stakeholders: Inform supervisory staff, Quality Control (QC), and Quality Assurance (QA) personnel about the findings.
    4. Document the Incident: Initiate an incident log to record all relevant details such as time, location, and observations.
    5. Initiate a Temporary Hold: Place a hold on all related stability studies and laboratory work pending further investigation.

    Investigation Workflow

    The investigation process should be systematic to ensure thoroughness. Here’s a recommended workflow for assessing stability data gaps:

    1. Gather Relevant Data: Collect all stability testing results, batch records, analytical methods, and equipment logs.
    2. Engage Teams: Involve cross-functional teams, including QA, Engineering, and Production, to evaluate all possible contributing factors.
    3. Data Interpretation: Analyze the collected data against regulatory expectations and internal standards. Identify patterns or trends that require deeper examination.
    4. Analyze Testing Protocols: Review the testing methods and protocols for compliance with applicable regulatory requirements.
    5. Conduct Interviews: Discuss with relevant personnel to uncover any procedural deviations or potential misunderstandings regarding processes.

    Root Cause Tools

    Employing effective root cause analysis tools can provide insights beyond initial symptoms. Below are several methods to consider:

    • 5-Why Analysis: Use this technique to drill down through the “why” of each observation until you reach the underlying cause.
    • Fishbone Diagram: Also known as the Ishikawa diagram, this tool helps visualize potential causes of stability issues and can facilitate team brainstorming.
    • Fault Tree Analysis: This top-down approach allows for systematic exploration of failure causes, particularly in complex systems.

    Choose the method that best fits the complexity of the issue. For example, the 5-Why method is effective for simpler issues, while the Fishbone diagram may be more useful in collaborative settings.

    CAPA Strategy

    Implementing a robust CAPA strategy is essential for managing and preventing future stability data gaps. Follow this structured approach:

    1. Correction: Address any immediate deviations by recalling affected batches and correcting affected records.
    2. Corrective Action: Identify measures to address root causes. This may include revising protocols, retraining personnel, or upgrading equipment.
    3. Preventive Action: Develop long-term strategies to prevent recurrence, such as enhanced quality control measures, regular training, and better supplier engagement.

    Control Strategy & Monitoring

    A solid control strategy is crucial for ensuring ongoing compliance and stability throughout the product lifecycle. Key components include:

    Related Reads

    • Statistical Process Control (SPC): Use control charts and trend analysis to monitor stability testing results and detect deviations early.
    • Regular Sampling: Implement regular sampling of stability batches and adhere to a predefined testing schedule.
    • Alarm Systems: Use automated alarms to signal deviations in environmental conditions (temperature, humidity) during stability storage.
    • Verification Practices: Regularly verify analytical techniques to ensure consistent performance and correctness of results.

    Validation / Re-qualification / Change Control Impact

    Adjustments in procedures and methods to address stability data gaps often trigger the need for re-evaluation and validation. Key considerations include:

    • Validation of Changes: Any changes to processes affecting stability data will require a thorough validation to confirm their effectiveness.
    • Re-qualification: Ensure that any affected equipment is re-qualified following significant changes or corrective actions to ensure reliability.
    • Change Control Process: Follow established change control protocols for documenting any adjustments to practices or materials, ensuring all aspects comply with regulatory requirements.

    Inspection Readiness: What Evidence to Show

    Being prepared for inspections is critical, particularly in the wake of identified issues. Ensure the following documentation is readily available:

    • Incident Logs: Clearly documented incidents including detailed descriptions, timelines, and corrective steps taken.
    • Batch Records: Comprehensive and accurate batch records, including stability test results and compliance checks.
    • Deviations and CAPAs: Complete documentation of deviations and CAPA initiatives, including data analysis and outcomes.
    • Training Records: Maintain logs of any training sessions and related materials provided to personnel involved in stability assessments.

    FAQs

    1. What is the importance of stability data in WHO PQ assessments?

    Stability data demonstrates how a drug product maintains its quality over time, which is crucial for gaining WHO PQ approval and ensuring patient safety.

    2. How do I identify stability data gaps?

    Symptoms such as OOS results, missing information in stability studies, and inconsistencies in batch records can indicate potential gaps in stability data.

    3. What is the first step I should take upon discovering a gap?

    Immediately halt any operations involving the affected batches, document the observation, and notify relevant stakeholders.

    4. Which root cause analysis tool is the most effective?

    The best tool depends on the complexity of the issue; the 5-Why method is ideal for straightforward problems, while Fishbone diagrams can facilitate collaborative investigations.

    5. How do I ensure ongoing compliance after addressing stability data gaps?

    Implement robust monitoring systems, regular sampling, and enhanced training for personnel to sustain compliance and prevent recurrence.

    6. What should be included in CAPA documentation?

    Include details of the corrective and preventive actions, timelines for implementations, personnel involved, and any follow-up measures taken to evaluate effectiveness.

    7. How often should stability studies be reviewed?

    Stability studies should be regularly reviewed with every product cycle, especially post-manufacturing alterations or upon receiving OOS results.

    8. What role does change control play in stability data management?

    Change control ensures all modifications affecting stability assessments are thoroughly documented, validated, and reviewed, maintaining compliance.

    Pharma Tip:  Stability data gaps during requalification – how to defend manufacturing readiness